02.05.2013
- Teva Pharmaceutical Industries is banking on approval in early 2014 for a new thrice-weekly version of its multiple sclerosis treatment Copaxone to bolster sales ahead of a likely...
01.11.2012
- Teva Pharmaceutical Industries, the world's biggest generic drugmaker, posted adjusted quarterly profit that beat expectations as strong U.S. revenue offset lower European generic...
